Vaccine factory goes up fast; large volume expected
Share - WeChat


A new factory producing COVID-19 vaccines started up in Wuhan, Hubei province, on Monday after 86 days of construction, the builder said.
It is the second phase of vaccine production affiliated with the Wuhan Institute of Biological Productions Co of Sinopharm, a State-owned pharmaceutical company. It has a designed annual production capacity of 1 billion doses, according to a statement by China Construction Third Engineering Bureau Group, the second phase builder.
The new factory is expected to produce 600 million vaccine doses for COVID-19 by the end of this year.
Related Stories
- Chinese researchers uncover gene defect as key driver of lupus
- Strength of forests: Zhang Yufei promotes eco-activism in new ad
- China introduces childcare subsidy system in push for population growth
- China's child overweight, obesity rates drop to below 10%
- Shanghai tech conference showcases AI in action
- Tsinghua medicine council aims to strengthen its global role